← Russell 3000 cross-section

NRC NRC HEALTH

Trailing twelve months to 2026-06-30 · as filed 2026-08-04, not restated
Healthcare

Scale

Market cap
$494m
Revenue TTM
$140m
Net income TTM
$6m
Free cash flow
$22m
Composite score
47.3
Sector rank
#2408

Valuation

P / E
84.3
EV / EBITDA
EV / sales
4.1
FCF yield
4.38%
Earnings yield vs 10-yr
-3.54pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
4.2%
EBITDA margin
ROE
89.5%
ROIC
16.5%
Revenue growth
-0.2%

Insider activity, last 90 days

Net open-market
$0.00m
Buyers
0
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Total revenue for the three months ended June 30, 2026, was $ 35.4 million, compared to $ 34.0 million for the three months ended June 30, 2025. Total revenue for the six months ended June 30, 2026, was $ 70.2 million compared to $ 67.6 million for the six months ended June 30, 2025. The increases were primarily attributable to growth in subscription‑based services. The following table provides information about receivables, contract assets, and contract liabilities from contracts with customers (in thousands): Deferred revenue increased by $ 0.5 million primarily due to new billings exceeding revenue recognized during the period. …NRC HEALTH, 10-Q, period ended 2026-06-30, filed 2026-08-04

Read the full passage →